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(57) ABSTRACT
A system and method for signal processing to remove
unwanted noise components including: (1) wavelength-in-
dependent motion artifacts such as tissue, bone and skin
effects, and (11) wavelength-dependent motion artifact/noise
components such as venous blood pulsation and movement
due to various sources including muscle pump,respiratory
pump and physical perturbation. Disclosed are methods,
analytics, and their uses for reliable perfusion monitoring,
arterial oxygen saturation monitoring, heart rate monitoring
during daily activities and in hospital settings and for
extraction of physiological parameters such as respiration
information, hemodynamic parameters, venous capacity,
and fluid responsiveness. The system and methods disclosed
are extendable to include monitoring platforms for perfu-
sion, hypoxia, arrhythmia detection, airway obstruction
detection and sleep disorders including apnea.
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SYSTEMS AND METHODS FOR
PHYSIOLOGICAL SIGNAL ENHANCEMENT
AND BIOMETRIC EXTRACTION USING
NON-INVASIVE OPTICAL SENSORS
CROSS REFERENCE TO RELATED
APPLICATION
This application claimspriority to U.S. Provisional Appli-
cation No. 61/926,773 filed Jan. 13, 2014. The above
identified patent application is incorporated herein by ref-
erence in its entirety to provide continuity of disclosure.
FIELD OF THE INVENTION
The present invention relates to systems and methods for
enhancing physiological signals taken by optical biosensors
at different human body sites. In particular, the present
invention relates to enhancing photoplethysmographic sig-
nals for pulse oximetry, extraction of heart rate, and extrac-
tion of other physiological parameters such as respiratory
information, fluid responsiveness, perfusion level and other
hemodynamic parameters.
BACKGROUND
Photoplethysmography is a non-invasive measurement of
the blood flow at the surface of the skin of a human by using
two-wavelength lights, such as red (R) and infrared (IR)
lights, to generate photoplethysmographic (“PPG”) signals.
Two commonusesofthe PPG signals are calculations of the
arterial oxygen saturation and heart rate. Several applica-
tions that require various analyses of the PPG signals
include amplitude, rhythm, peripheral pulse, respiratory
variability and tissue perfusion. For example, increased and
decreased signal amplitude can indicate signs of vasodila-
tion and vasoconstriction, respectively. The amplitude is
directly proportional to the vascular distensibility. PPG
signals are also useful for the detection and diagnosis of
cardiac arrhythmias. Further, a PPG signal is known to be
sensitive to pulsatile blood flow and captures the peripheral
pulses. The pressure at which the pulse is captured highly
corresponds to the systolic blood pressure. The respiratory
rate can be determinedby a set of PPG signals. Noninvasive
continuoustissue perfusion and peripheral blood flow detec-
tion is another potential advantage of the PPG signal. All the
above-mentioned applications require a clean and enhanced
signal for feature extraction, analysis, and monitoring.
Therefore, the quality of the PPG signal is critical for
wearable PPG devices and systems.
For example, in wearable and implantable devices/appli-
cations, biometric signals need to be monitored during daily
activities where motion is always present. Motion artifact is
the most problematic source of noise which deteriorates
signal integrity and can, in the worst case, corrupt the PPG
signal to such an extentthat the signal is rendered clinically
unusable. Examples of motionsofthe patient in a real world
clinical setting include movementduring transport, rubbing,
waving, seizures, and kicking in neonates and infants. As a
result, inaccurate readings and interpretations of the PPG
signal due to motion artifact increases the workload of a
caregiver of the patient which leads to an increased cost of
care and inefficiency of patient’s treatment. Therefore, there
is a needin the art for an effective solution for wearable and
mobile PPG biosensors to enhance the signal quality in the
presence of motion artifact.
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The prior art has attempted to solve these problems with
limited success. For example, one commonly used method
to reduce the effect of motion artifact is adaptive noise
cancellation using accelerometers as a noise reference sig-
nal. A two-dimensional active noise cancellation uses the
directional accelerometer data for a finger PPG sensor.
Another method adds a reflectance PPG sensor as the
reference signal to reduce the effect of motion artifact.
However, the reflectance PPG sensoris itself susceptible to
motion artifact. The main drawback of all these methodsis
the cost of extra hardware for the generation of the noise
reference signal. Further, using accelerometer data is com-
putationally intensive and reflects motion as opposed to
motion-induced noise. More precisely, no direct or high
correlation between acceleration data from an accelerometer
and motion artifact in PPG signal has been found. This
method assumesthat the original PPG signal has only power
at certain frequencies with the remaining power assumed to
be noise and then uses Fast Fourier Transform (FFT),
Singular Value Decomposition and Independent Component
Analysis to generate three synthetic reference noise signals.
The method switches between the three reference noise
signals by quantifying the randomness of each signal using
skewness and kurtosis. These assumptions on motion arti-
fact do not correlate with different real-world sources of
noise. Moreover, the highest randomness does not necessar-
ily mean the highest correlation with the true motionartifact
in the PPGsignal.
In another example, Masimo Corporation has introduced
Discrete Saturation Transform (DST)to find pulse oximeter
oxygen saturation in the presence of motion in portable
devices. Typically, the DST method includes of a reference
signal generator, an adaptive filter and a peak finder to find
the most likely SpO, value based on the incoming signals. In
this approach, the reference signal generator producesref-
erence signals for all possible SpO, values. For each refer-
ence signal, the adaptive filter produces an output signal.
Energy of each output signal is computed and plotted versus
corresponding SpO, values. The right-most peak of the
powerplot (the largest saturation value) is nominally con-
sidered as oxygen saturation ofarterial blood flow. However,
this approach does not remove the motionartifact (e.g. due
to tissue effect). Consequently, the effect of motion artifact
is transformed to the output power plot in DST. More
specifically, in presence ofmotionartifact, new peaks will be
present on the output plot and the peak finderfails to find the
peak corresponding to accurate SpO,. Alternatively, the
peak corresponding to SpO,is concealed due to high motion
noise power causing the peak search to fail for that time
window.
Therefore, there is a need in the art for an effective
solution for wearable and mobile PPG biosensors to enhance
the signal quality in the presence of motion artifact.
SUMMARY
In a preferred embodiment, a system and method for
enhancing PPG signals are disclosed. Different sources of
motion-inducederror in the PPG signals, which include red
and infrared signals are identified, quantified and estimated.
Enhancedred andinfrared signals are produced by removing
these sources of motion induced error. A novel multi-stage
adaptive methodthat efficiently removes the effect of tissue
and venous blood noise during motion is disclosed. This
method extracts a fundamental period of the PPG signal, the
heart rate, and the oxygen saturation level. The method
US 9,918,666 B2
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produces a clean enhanced red and infrared PPG signal
corresponding to the arterial blood flow.
In one embodiment, an adaptive and direct capturing of
the motion artifact present in circulatory system, including
physical motions, respiration and skeletal muscle pumps,
and generating enhanced and artifact-free two-wavelength
(e.g. R/AIR) PPG signals is provided.
In another embodiment, separation and quantification of
arterial and venous pulsations of multi wavelength PPG
signals (e.g. R and IR) is provided.
In another embodiment, identification of biphasic cardiac
cycle and sub-heart-beat time intervals where extraction of
oxygen saturation and heart rate are minimally impacted by
artifact and maximally impacted by the main biometric
variation is provided.
In another embodiment, a method to produce a synthetic
noise reference is disclosed. The technique also uses a
method for estimating fundamental frequency and noise
reference.
In another embodiment, a first method to enhance red and
infrared PPG signals is provided and a methodis disclosed
to extract the heart rate value.
In another embodiment, a method to enhance red and
infrared PPG signals is provided in combination with a
cardiac gating method to extract the oxygen saturation
value.
BRIEF DESCRIPTION OF THE DRAWINGS
The disclosed embodiments will be described with refer-
ence to the accompanying drawings.
FIG. 1 is a general schematic of a PPG sensor and blood
circulation at a measurementsite.
FIG. 2 is a graph of a PPG signal and components of the
PPGsignal.
FIG. 3 is a schematic of a system for enhancing PPG
signals in a preferred embodiment.
FIG.4A is a flowchart of a model for optimizing a weight
of a preferred embodiment.
FIG.4B is a flowchart of a modelfor finding an optimized
weight of a preferred embodiment.
FIG. 5A is a flowchart of a method for enhancing a set of
PPGsignals of a preferred embodiment.
FIG. 5B is a block diagram of a system for enhancing a
set of PPG signals of a preferred embodiment.
FIG. 6A is a block diagram of an adaptive noise canceller
with reference noise of a preferred embodiment.
FIG.6B is a block diagram of an adaptive noise canceller
with a reference signal of a preferred embodiment.
FIG. 7 is a block diagram of a real-time fundamental
period estimator of a preferred embodiment.
FIG. 8 is a block diagram of an adaptive noise canceller
using synthetic noise reference of a preferred embodiment.
FIG. 9 is a block diagram of a motion-tolerant signal
enhancing andcardiac gating system of a preferred embodi-
ment.
FIG. 10 is a block diagram of a signal enhancement unit
of a preferred embodiment.
FIG. 11A is a graph of a sampling windowin a biphasic
cardiac activity of a preferred embodiment.
FIG. 11B is a graph of a sampling windowin a biphasic
cardiac activity of a preferred embodiment.
FIG. 11C is a graph of a sampling windowin a biphasic
cardiac activity of a preferred embodiment.
FIG. 11D is a graph of a sampling window in a biphasic
cardiac activity of a preferred embodiment.
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FIG.12 is a graph of respiratory effect on a baseline of a
preferred embodiment.
FIG. 13 is a block diagram of a cardiac gating unit of a
preferred embodiment.
FIG. 14 is a block diagram of a heart rate extractor of a
preferred embodiment.
FIG. 15 is a block diagram ofa correlation canceller of a
preferred embodiment.
FIG. 16 is a schematic of an experimental setup of a
preferred embodiment.
FIG. 17A is a graph of a raw red PPG signal during
various motions of an experiment of a preferred embodi-
ment.
FIG. 17B is a graph of a sample PPG signal during an
experiment of a preferred embodiment.
FIG. 17C is a graph of an autocorrelation of a preferred
embodiment.
FIG. 17D is a graph of a power spectrum of a preferred
embodiment.
FIG. 17E is a graph of a heart rate of a preferred
embodiment.
FIG. 17F is a graph of an SpO, of a preferred embodi-
ment.
FIG. 18A is a spectrogram of an original PPG signal of a
preferred embodiment.
FIG. 18B is a spectrogram of an enhanced PPG signal of
a preferred embodiment.
FIG. 19A is a graph of an ECG waveform from a
reference ECG sensorof a preferred embodiment.
FIG. 19B a sample PPG signal of a preferred embodi-
ment.
FIG. 19C is a graph of heart rates calculated from an
original signal and an enhanced signal.
FIG. 19D is a graph of a Bland-Altmanplot of an original
heart rate of a preferred embodiment
FIG. 19E is a graph of a Bland-Altman plot of an
enhanced heart rate of a preferred embodiment.
FIG. 19F is a graph of SpO, calculated from an original
signal and an enhancedsignal.
FIG. 19G is a graph of a Bland-Altman plot of SpO,
calculated from an original signal.
FIG. 19H is a graph of a Bland-Altman plot of SpO,
calculated from an enhancedsignal.
FIG. 20 is a graph of a power plot of the DST method.
FIG. 21A is a graph of a Bland-Altmanplot of heart rate
of a preferred embodiment.
FIG. 21B is a graph of a Bland-Altman plot of SpO, ofa
preferred embodiment.
FIG. 22 is a graph of a simulated portion of a noisy PPG
signal.
FIG. 23A is a graph of a simulated noisy PPG signal.
FIG. 23B is a graph of a fundamental frequency of a
preferred embodiment.
FIG. 23C is a graph of a portion of an autocorrelation
function.
FIG. 23D is a graph of an autocorrelation function.
FIG. 24A is a graph of an original PPG signal of a
preferred embodiment.
FIG. 24B is a graph of a heart rate calculated by a
fundamental frequency of a preferred embodiment.
FIG. 24C is a graph of an autocorrelation function.
FIG. 25A is a graph of a motion corrupted PPG signal.
FIG. 25Bis a graph of an improved PPGsignal from an
adaptive filter of a preferred embodiment.
FIG. 25C is a graph of a synthetic noise reference in time
domain of a preferred embodiment.
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FIG. 26A is a spectrogram of a motion corrupted PPG
signal.
FIG. 26B is a spectrogram of an improved PPG signal of
a preferred embodiment.
FIG. 26C is a spectrogram of a synthetic noise reference
of a preferred embodiment.
DETAILED DESCRIPTION
Tt will be appreciated by those skilled in the art that
aspects of the present disclosure may be illustrated and
described in any of a number of patentable classes or
contexts including any new and useful process or machine or
any new and useful improvement. Aspects of the present
disclosure may be implemented entirely in hardware,
entirely in software (including firmware, resident software,
micro-code, etc.) or combining software and hardware
implementation that may all generally be referred to herein
as a “circuit,” “module, unit”, “block”, “method”,
“model”, “component,” or “system.” Further, aspects of the
present disclosure may take the form of a computer program
product embodied in one or more computer readable media
having computer readable program code embodied thereon.
Any combination of one or more computer readable
media maybe utilized. The computer readable media may be
a computer readable signal medium or a computer readable
storage medium. For example, a computer readable storage
medium maybe, but not limited to, an electronic, magnetic,
optical, electromagnetic, or semiconductor system, appara-
tus, or device, or any suitable combination of the foregoing.
More specific examples of the computer readable storage
medium would include, but are not limited to: a hard disk,
a random access memory (“RAM”), a read-only memory
(“ROM”), an erasable programmable read-only memory
(“EPROM”or Flash memory), an appropriate optical fiber
with a repeater, a portable compact disc read-only memory
(“CD-ROM”), an optical storage device, a magnetic storage
device, or any suitable combination of the foregoing. Thus,
a computer readable storage medium may be any tangible
medium that can contain, or store a program for use by or in
connection with an instruction execution system, apparatus,
or device.
Acomputer readable signal medium mayinclude a propa-
gated data signal with computer readable program code
embodied therein, for example, in baseband or as part of a
carrier wave. The propagated data signal may take any of a
variety of forms, including, but not limited to, electro-
magnetic, optical, or any suitable combination of them. A
computer readable signal medium may be any computer
readable medium that is not a computer readable storage
medium and that can communicate, propagate, or transport
a program for use by or in connection with an instruction
execution system, apparatus, or device.
Computer program code for carrying out operations for
aspects of the present disclosure may be written in any
combination of one or more programming languages,
including an object oriented programming language such as
Java, C++, C#, .NET, Objective C, Ruby, Python SQL,
MATLAB, or other modern and commercially available
programming languages.
One of the main applications of PPG biosensors is mea-
suring blood oxygen saturation. The commercial device
built based uponthis technology is a pulse oximeterthat uses
two or more wave-length lights, such as red and infrared
lights. Pulse oximetry may be used to quantify various blood
29 66.
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flow characteristics including arterial oxygen saturation, the
volume of blood pulsation carried to the tissues, and the
heart rate.
Referring to FIG. 1, a pulse oximeter typically uses a set
of light emitting diodes (LEDs) 101 with wavelengths in red
and infrared regions which emit light at measurementsite
100 on a human body. Photodetector 102 captures the
transmittedor reflected light. The analog front-end hardware
uses a time multiplexed approach with three phases: (1) an
activated red LED phase, (ii) an activated infrared LED
phase, and (iii) a dark phase. A transimpedance amplifier
amplifies the current generated in the photodetector due to
optical density during active phases and provides a voltage
signal. The voltage signalis filtered, amplified, and sampled
with an analog-to-digital converter for further processing.
The basic circulation of blood is conducted by the heart,
which pumps blood periodically and rhythmically into a
branching system of arteries. At measurementsite 100 (e.g.
finger, ear, forehead, nasal), tissues 105 and 106 slightly
expand during each heart beat as arterial blood 107 enters
capillaries 108 via arteries 103 during systole. The pulsa-
tions generated periodically by the heart will dampen by the
time they reach capillaries 109, which are in contact with
cells of tissues 105 and 106. Venous blood 109 then returns
via veins 104 in an almost steady stream to the heart with
another pulsation stimulated in veins 104 by muscular
activity and the respiratory pump. Measurementsite 100
contracts as venous blood 109 leaves during diastole. As a
result, the path length of the light from the set of LEDs 101
will periodically change. Absorption is proportional to the
optical path length according to the Lambert law ofoptical
density and the volume change will bereflected in the output
of photodetector 102. An electronic interface captures these
changes via photodetector 102 on the measurementsite 100
and provides the PPG signal having a set of component
signals.
Referring to FIG. 2, PPG signal 201 includes arterial
blood component 202, venous blood component 203, cap-
illary blood component 204, and skin, bone and tissue
component 205.
Referring to FIG. 3, system 300 includes PPG sensor 301
connected to evaluation module 302 and computing device
303 connected to evaluation model 302. PPG sensor 301
includes red LED 304 and infrared LED 305 and a photo-
detector. Computing device 303 includes processor 306 and
memory 307 connected to processor 306. Signal enhance-
ment and extraction method 308 is saved in memory 307 and
is executed by processor 306. Evaluation module 302
includes a set of filters and computational units such as
multipliers, as will be further described below. Evaluation
module 302 receives a red signal from red LED 304 and an
infrared signal from infrared LED 305. Evaluation module
302 processes the red signal and the infrared signal accord-
ing to signal enhancement and extraction method 308, as
will be further described below.
In one embodiment, computing device 303 is a personal
computer. In another embodiment, computing device 303 is
a tablet computer. In another embodiment, computing device
303 is a smartphone. Any computing device knownintheart
may be employed.
In one embodiment, computing device 303 is a wearable
device, including a wrist-worn device or an electronic patch.
In this embodiment, processor 306 and memory 307 are
embedded. Any wearable computing device knowninthe art
may be employed.
In a preferred embodiment, sensor 301 is a wearable
sensor that uses red and infrared LEDs working at 660 nm
US 9,918,666 B2
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and 895 nm,respectively. Any pulse oximetry sensor known
in the art may be employed. Other sensors on various
locations of the body andreflection or transmission mode
sensors may be employed.
In a preferred embodiment, evaluation module 302 is an
analog front end circuit with an onboard processor. Any
evaluation module known in the art may be employed or a
custom printed circuit board with custom analog front end
may be employed for different applications. The evaluation
module includes an analog conditioning circuit which limits
the bandwidth of the PPG signal to 70 Hz. In one embodi-
ment, a hamming window and a low-passfilter, with cutoff
frequency at 8 Hz, are implemented on the evaluation
module in order to attenuate any unwantedsignals.
The source of the PPG signal, red or infrared, is the
optical density transmitted or reflected. The basis of optical
absorption is defined by Lambert-Beer’s law that explains
the optical density (A) for both scatterer and nonscatterer as:
Eq. 1 A LinA= log{ =
out
)=E-C-D
where L,,, and L,,,, are incident and transmitted light inten-
sities, respectively, and C and D are the concentration and
thickness of the optical absorber, respectively. E is an
extinction coefficient which is intrinsic to the absorber and
wavelength. The assumption in this formulation is that the
object is uniform and nonscattering and so it only provides
a rough estimation about scatterers.
Twobasic theories of optical scattering, which gives a
more precise prediction of scattering behaviors, are Ray-
leigh-Mie’s theory and Schuster’s theory. Aoyagi who
reported the principle of pulse oximetry in 1974 has adopted
the Schuster’s theory and introduced the optical theory
behind photoplethysmography. The following relationship
describes the optical density changes AA as a function of
blood vessel thickness changes AD,for a given blood vessel:
 Ad=[VE,(E,+F)Hb+Z,JAD, Eq. 2
where E,4 S E,+(1-S)E,, in which E, and E, are the
extinction coefficient of oxyhemoglobin and deoxyhemo-
globin, respectively. S is oxygen saturation, Hb is hemoglo-
bin concentrations of the blood and F is the scattering
coefficient. Z, is a constant which becomes zero when the
optical receiver is wide enough and independent of the
working wavelength. Tissue effect is one ofthe main sources
of error in obtained optical density leading to undesired
fluctuation in acquired PPG signals. Considering the effect
of tissues, Eq. 2 is modified by adding a new term (Z, AD,)
and becomes:
A4=VE,(E,+FHBAD+Z,AD+Z,AD,
where Z, 1s approximatedto be a constant independent of the
wavelength and AD, is thickness change of the tissue.
Therefore, there is an optical density change (e.g. Z, AD,+Z,
AD,) which is wavelength-independent. Eq. 3 considers only
one blood vessel. Considering the effect of arterial blood
vessels and venous blood vessels, there are arterial blood
changes and venous blood changes. Therefore, AA is
expressed as:
Eq. 3
Ad=VE,(E,+FHbAD,VE,(E,+F)HbAD,+4,
Subscripts a and v refer to arterial blood and venous blood,
respectively. AD, and AD, are venous andarterial blood
thickness changes, respectively. AA, is independent of
Eq. 4
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wavelength and it captures the accumulated wavelength-
independent effect of blood and tissue thickness changes.
Hb, and Hb,are arterial and venous hemoglobin concentra-
tions, respectively.
As will be described below, an optical density is formu-
lated to define a reference signal and a reference noise signal
for removal of a tissue effect and a venouseffect, respec-
tively. The arterial signal is modeled and a cost function is
defined to find the optimum noise reference for removal of
venouseffect over time.
When the body remainsstill, AD, is close to zero and the
effect of tissue manifests itself as a DC component in the
recorded PPG signal. This DC component can be removed
in analog front-end or by digital filtering. However, in the
presence of motion, this component is no longer constant.
Fluctuations caused by body movements, for example dur-
ing walking, running andtreadmill exercise, can be seen in
the recorded PPG signal. Such new rhythmic pattern and
variation in the PPG signal can lead to an inaccurate and
unreliable fundamental period for the PPG signal. To over-
comethese issues, two wavelengths are employed to cancel
out the effects of Z,, and Z, that are independent of the
wavelength. In a preferred embodiment, optical densities
that correspond to a two-wavelength PPG biosensor, as
defined in Eq. 4, are subtracted (subscript i andj are used for
wavelengths and t to represent tissue effect), and define the
result by:
Ady=|E,,(EatP)-VE,(Eg+P)Hb,AD+
(VE(EEAP)-VE,(E,,4F)|Hb,AD,
The term AA, in Eq. 4 is independent of wavelength and
the time difference between recording of both wavelengths
is negligible compared to typical time for human motions.
This term is now effectively removed in Eq. 5. Conse-
quently, the signal portion due to blood pulsation will remain
in AA,, and the effect of tissue during body movementwill
be canceled out.
In a preferred embodiment, a reference signal defined by
AA,,, is generated and used in an adaptivefilter to enhance
signal quality for extracting a PPG fundamental period. The
PPG fundamental period will, therefore, be reliably
extracted after signal enhancement using the generated
reference signal. In another embodiment, the wavelength-
independent, 1.e., the tissue effect, is applied to more than
two wavelengths to remove the tissue noise effect.
Another main source of error and interference is the
change of venous blood during motion artifact. The effect of
venous blood appearsin the calculation ofoxygen saturation
more noticeably while the effect of tissue hinders extraction
of heart rate. Motion artifact due to tissue effect is removed
using AA,,, as a reference signal. The removal of motion
artifact is equivalent to setting AA, of Eq. 4 equal to zero.
Nowthat AA, is equal to zero, Eq. 4 for the removal effect
of venous blood movementis as follows for a two-wave-
length PPG biosensor:
Eq. 5
AA; = «{ Ea;(Ex; + F) HbgADg + «[Ey,(Ey, +F) HbAD, Fa 6
AAj = 4 Ea,(Ea; + F) Hb,ADq + \ Ey;(Ey, + F) HbyAD,i i i i
Each of the two sources of information, AA, and AA,is
a mixture ofarterial blood, represented by subscript a, and
venous blood, represented by subscript v, at a particular
wavelength (i,j). Each first term of optical density in Eq. 6
represents the arterial blood signal and each second term
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represents the venous blood signal. Weighted subtraction of
these two sources is employedto calculate, a reference noise
signal, 1.e., AA,,=AA,-B AA,. Eq. 6 becomes:
AAgy = [ra - By Ea; (Ea, + F) |HbgADa + Eq. 7
[oy — By Ey (Ey, + F) |HbyAD,
Ey, (Eq, + F) I Ea; (Ea; +F)
Ey,(Ey, + F) yy Eyj(Ev; + F)
where r, is the ratio of arterial optical densities which is
linearly related to arterial oxygen saturation andr,, is the
ratio of venousoptical densities. After removal of thetissue
effect, the weighted subtraction of optical densities in Eq. 7
is used to separate two signal sources related to artery and
venous. Eq. 7 indicates that with proper tuning of the weight
B, the reference noise signal defined by AA,,,, may contain
a venous componentsignal, i.e. B=r,, an arterial component
signal i.e. B=r,, or a combination of these two sources. In
other words, 6 is swept and a reference noise signal is
generated for the various values of B. As can be seen in Eq.
7, there is a range of f where the reference noise signal has
the venous component signal and a wider range of § where
the reference noise signal has the arterial componentsignal.
Separation of the venous component signal in Eq. 7
enables use of the venous componentsignal as the reference
noise signal in an adaptive filter to remove the venous noise
from Eq.6, i.e., generate a venous noise reference signal. In
order to find 6 that removesarterial componentsignal, 1.e.,
the first term of Eq. 7, and keep the venous component
signal, a set of criteria is needed to quantify the performance
of any given B. The arterial componentsignal is a periodic
signal with a temporal structure. The more pronounced
periodic property of the arterial term in Eq. 7 will be
exploited by the subsequent adaptive and prediction error
filtering to separate these two signals to estimate of arterial
componentsignal. As will be described below, the optimum
B(B.,.) is used in estimating the venous noise reference
signal and to implement an adaptive filter for removal of
venous blood movementnoise.
Referring to FIG. 4A, model 400 for optimizing 6 will be
described. Model 400 includes weighted subtractor 401,
adaptive enhancer 402, and predictor filter 403. Adaptive
enhancer 402 removes the second term of AA, in Eq. 6 and
keeps the arterial component signal using the output of
weighted subtractor 401 as the reference noise signal 404.
Predictionfilter 403 is used to predict the arterial component
signal using previous valuesofthe arterial component signal
and generate prediction error 405. Each of input signal 406
xX, and input signal 407 x, corresponding to the optical
densities AA, and AA, in Eq.6, is a linear combination of
arterial and venoussignals. Usingarterial and venousoptical
density ratios, r, and r,, defined in Eq. 7 , input signal 406
x, and input signal 407 x, are expressed as:
{= = FaSa + MvSv Eq. 8
X2 =SgtSy
Weighted subtractor 401 generates a weighted subtraction
of input signals 406 and 407 x, and x, and generates a
referencenoise signal 404 corresponding to AA,,,, in Eq.7.
Adaptive filter 408 uses reference noise signal 404 to filter
out the noise, i.e., the second term of Eq. 6, which is the
venous component signal, thereby leaving arterial compo-
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nent signal 409 intact. Arterial component signal 409 is a
temporally correlated signal. Adaptive enhancer 402 com-
bines arterial componentsignal 409 with input signal 406 x,
to generate enhanced arterial component signal 412. As
shown, the temporal structure of an enhancedarterial signal
412 is modeled with adaptive enhancer 411 with the z-trans-
form of B(z) at the output 410 of adaptive enhancer 411.
Adaptive enhancer 411 models enhancedarterial signal 412,
r,8,(0). B(z) in adaptive enhancer 411 estimates enhanced
arterial componentsignal 412 r,s, for any given £. For the
optimum value of B(B,,,) at 413,
1SaNEy(Eat)HbAD, Eq. 9
where VE,,@,,+F)Hb AD, is the first term of AA,, which is
a predictable (periodic) signal, and represents the arterial
componentsignal. Therefore, for B,,,,, the variance of the
prediction error 405 will be minimized.In orderto find B
model 414 of FIG. 4B is employed
Referring to FIG. 4B, in model 414 a linear combination
of input signals 406 and 407 x, andx5,i.e. x,-Bx, with B,,,,
provides an estimate of the reference venous noise signal at
419, where
op
ar,
Bopt = l-a@
Model 414 extracts a scaled estimate 415, s,,, of the
arterial component signal in input signal 406 x, at 422 and
minimizes the variance of the error signal 417 e(n) at the
output of linear predictor 416. Error signal 418, e, is the
difference between a current sample of scaled estimate 415,
$,s(0), and the output B(z) of the linear predictor 416,i.e.,
error signal 417 e(n).
In one embodiment, linear predictor 416 is a Finite
Impulse Response (FIR) filter. In another embodiment,
linear predictor 416 is an Infinite Impulse Response (IIR)
filter.
Therelation between error signal 417 and scaled estimate
415 is mathematically expressed as:
e(2)=(1-BE))8.5()
Generally, the FIR embodimentofpredictionfilter 416 of
order P can be expressed as:
Eq. 10
P Eg. 11Ba) = Yi bc!
&0
Optimization of r, at 421 and coefficient b of B(z) is
determined by minimizing the mean square error defined as
the cost function:
Mr, b)=Ele?] Eq. 12
where b is the vector of coefficient of prediction filter 416.
In order to simplify the computation and use the extracted
fundamental period of the signal, a linear predictor is
chosen, B (z)=b z-**, where T,, is the fundamental period of
the arterial componentsignal in discrete time and b is the
only coefficientofthe filter. The cost function, E[e*], is now
written as:
JB)=E[Sas)|-2BE[Sag)Sas(H-T.g)+bPE[S,.2(n-T,)] Eq. 13
When the gradients of the cost function with respect to r,
and b are zero, the predictionerror, error signal 417 e(n), has
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its minimum value. So, by equating the gradient of the cost
function with respect to r,, and b to zero, we obtain a system
of equations. Solving this system of equations for r, and b,
results in:
_ ~EL{JEBaspx2] + Elx21ESasp~1] Eg. 14
"EDIEasp%1] — Elx2]EDBasp*2]
b = E[Sas()Sas(t — Ta)]/ ElSas(n - Ta) Eg. 15
For every given b, including b for which
ad (ry,b)») 6
ary
 
the error curve is a quadratic function of r,, that includes a
single minimum onthe error curve. After extraction of the
scaled estimate 415 §,, of the arterial component signal in
input signal 406 x,, the reference noise signal 419 is
extracted by removing the scaled estimate 415 §,, of the
arterial componentsignal from input signal 406 x,by mini-
mizing the variance of signal e,, reference noise signal 419.
By taking gradient of E[e,*] with respect to a at 420, we
obtain:
Elxt] - yELxx] Eq, 16
Eas]
Signal e, is the reference noise signal 419. As aresult, the
linear combination of signals x, and x, (i.e. x,-Bx,) with
optimum p,
ar,
Bopt = l-@
provides an estimate of the reference venous noise signal at
419.
Referring to FIG. 5A, method 500 for signal enhancement
and extraction of SpO, and heart rate will be described. At
step 501, motion noise due to a tissue effect is removed from
a red PPGsignal and an infrared PPG signal generating an
enhanced red PPG signal and an enhanced infrared PPG
signal. At step 502, a fundamental period is extracted using
the enhanced red PPG signal. At step 503, an optimal venous
noise reference signal is determined using the enhanced red
PPGsignal and the enhanced infrared PPG signal. At step
504, the enhanced red PPG signal and the enhancedinfrared
PPGsignal are further enhanced using a time-variant opti-
mum venousnoise reference signal to generate a clean red
PPGsignal and a clean infrared PPG signal. At step 505, a
heart rate and a SpO,is calculated using the clean red PPG
signal and the clean infrared PPG signal.
Referring to FIG. 5B, a block diagram of system 506 that
implements method 500 will now be described. Red signal
507 andinfrared signal 508 are subtracted at 509 to generate
reference signal 510. Reference signal 510 corresponds to
AA,,in Eq. 5. Reference signal 510 is used in adaptive
filters 511 and 512 to remove motion noise due to tissue and
to generate enhanced red signal 514 and enhancedinfrared
signal 513, respectively.
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Enhanced red signal 514 is connected to extractor 515.
Extractor 515 extracts fundamental period 516 from
enhancedred signal 514. Extractor 515 is further connected
to linear predictor 518. Linear predictor 518 receives fun-
damental period 516.
After removing motion noise due to tissue effect and
extracting fundamental period 516 T,, enhanced red signal
514 x, and enhanced infrared signal 513 x, are defined by
AA, and AA, of Eq.6, respectively.
Enhancedinfrared signal 513 and enhancedred signal 514
are connected to optimizer 517. Optimizer 517 is connected
to linear predictor 518. Optimizer 517 and linear predictor
518 generate an optimum weight B 519 (B,,,,), as previously
described in FIGS. 4A and 4B. Extracted fundamental
period 516 is used in linear predictor 518 to generate
prediction error 531 e. The optimum weight B 519 (B,,,,) is
updated using update rules defined by Eq. 14 and Eq. 16 for
r, and a, respectively. This process is done on a frame basis
and for each frame a new f.,,,, is extracted. B,,,, provides an
optimum reference noise, consequently, a set of clean sig-
nals contain only arterial component needed to extract
features such as SpO,.
Weighted subtraction of enhanced infrared signal 513 and
enhanced red signal 514 with current B,,,, is used to form
reference noise 513 defined by Eq. 7 for adaptivefilters 524
and 525. Optimum weight B 519 (B,,, ) is combined with
enhancedinfrared signal 513 at 520 to form combined signal
521. Combined signal 521 is combined with enhanced red
signal 514 at 522 to generate reference noise 523. Adaptive
filter 524 uses reference noise 523 to remove noise from
enhanced infrared signal 513 to generate clean infrared
signal 526. Adaptive filter 525 uses reference noise 523 to
remove noise from enhanced red signal 514 to generate
clean red signal 527. Dominant and high power motion noise
conceals the waveform amplitude of arterial component
when no enhancement algorithm is applied. The disclosed
embodimentprovides clean signals at the output preserving
peak-to-peak values of the arterial signal for amplitude
analysis.
Clean infrared signal 526 and clean red signal 527 are
received by extractor 528. Extractor 528 uses clean infrared
signal 526 and clean red signal 527 to calculate SpO, 529
and heart rate 530.
In one embodiment, the ratio of ratios method is
employed for the measurement of SpO,in pulse oximetry.
This method extracts the DC and AC parts of the clean red
and infrared PPG signals and computestheratio of ratios, R,
as:
_ RaclRac Eq. 17
~ [RaclTRae
where R,.. andR,, denote the magnitudesofthe pulsatile and
the DC parts, respectively, of the clean red signal. IR, and
R,, are the magnitudes of the pulsatile and DC portions of
the clean infrared signal, respectively. In one embodiment,
SpO,is then calculated by employing the following empiri-
cal equation:
Sp09%=(K+K2R)% Eq. 18
where K, and K, are constants empirically found and tuned
for a particular sensor platform. For example, K, is 105 and
K, is -23. Other values for K, and K, may be employed.
In another embodiment, a correlation-canceller based
SpO, extraction method is employed, as will be further
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described below. In another embodiment, Eq. 18 and the
correlation-canceller based method are alternatively
employed on the type of the motion and the level of the
venous blood movement. For example, Eq. 18 is employed
on various types of physical motion such as those moving
hands/legs, sit-stand body moves, bending, walking, running
and their corresponding changes in the levels of venous
blood movement. For example, the correlation-canceller
based method is employed on various types of motions
related to skeletal muscle pump and respiratory pump and
their corresponding changes in the levels of venous blood
movement. The correlation-canceller based method may be
employed during lower rate of change of oxygen saturation
or transient severe motion.
In a preferred embodiment, the fundamental period is the
heart rate. In one embodiment, the heart rate is calculated
using extractor 515. In another embodiment, any known
heart rate extraction method may be employed based on the
application and the need once the clean red and infrared
signals are obtained.
In another embodiment, a correlation-based heart rate
extractor is employed to calculate the heart rate, as will be
further described below.
Referring to FIGS. 6A and 6B,each ofthe adaptive filters
$11, 512, 524, and 525 will be further described. Each of
adaptive filters 524 and 525 will be further described as
adaptive filter 600. Each of adaptive filters 511 and 512 will
be further described as adaptive filter 610. Each of adaptive
filters 600 and 610 includesa filtering process that applies a
linear filter on a reference input.
Referring to FIG. 6A,filter 603 is applied to reference
noise 602 I,. Reference noise 602 I, is linearly correlated
with d(i), the noise componentin signal 601 I,. By subtract-
ing output 604 d(n) of filter 603 from signal 601 s(n)+d(n)
at 605, enhanced signal 609 and error estimation 606 are
generated. Adaptive process 607 automatically updates coef-
ficient 608 offilter 603 based on a set of criteria extracted
from error estimation 606. The set of criteria is defined by
adaptive process 607, as will be further described below.
Referring to FIG. 6B,filter 613 is applied to reference
signal 612 I, to generate enhanced signal 614 s(n). Enhanced
signal 614 s(n) is subtracted from signal 611 s(n)+d(n) to
generate error estimation 616. Adaptive process 617 auto-
matically updates coefficient 618 offilter 613 based on a set
of criteria extracted from error estimation 616. The set of
criteria is defined by the adaptive process 617, as will be
further described below.
Referring to FIGS. 6A and 6B, for each of adaptive
processes 607 and 617, the Least-Mean-Square (LMS)pro-
cess andits variations are employed.In a preferred embodi-
ment, each of adaptive processes 607 and 617 is the NLMS
method due to its lower complexity compared with other
techniques and immunity to the fluctuation in the signal
energy. Other adaptive optimization techniques including
recursive least square may be used.
In a preferred embodiment, each offilters 603 and 613 is
a linear filter. In another embodiment, each offilters 603 and
613 is a nonlinearfilter.
Given the desired output signal, input reference I, and the
current value ofthe filter coefficient w(n), the update equa-
tion for each of adaptive processes 607 and 617 is expressed
as:
2n Eq. 19wart l= win) + —> bien)
e+ > Bin-d
i=0
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where N is the length of the adaptive filter and 0<rn<1 and
€ is a small number, for example 0.0003, to avoid division
by zero due to numerical and fixed point computations. Error
estimations 606 and 616 are s(n)+d(n)-d(n) and d(n)+s(n)-
s(n), respectively. In adaptive filter 600, the reference input
is only correlated with the noise source. Therefore, mini-
mizing error power minimizes the noise power in mean
square sense and enhanced signal 609 is obtained at the
output. Similarly, in adaptive filter 610, the reference input
is only correlated with the signal source s(n). Therefore,
minimizing error powerresults in an enhanced noise at the
primary output 620, and an enhanced signal output 614 s(n).
An input red or infrared signal corrupted by motion noise is
the desired input signal in adaptivefilter 610. The reference
signal 611 represents the true signal.
Referring to FIG. 7, step 502 will be further described as
method 700. Method 700 assumes that the period stays the
same, i.e. the signal is stationary on each frame. At step 702,
an autocorrelation 706 of an enhanced signal 701 is com-
puted. In this step, the autocorrelation function C(t) pre-
serves periodicity information of enhanced signal 701.
When N samples of enhanced signal 701 are available, the
autocorrelation is expressed as:
1 Net Eq. 20CO= FD Medn(n+y
n=0
for N larger than several times the period T, of C(t) where
X,(n) is enhanced signal 701 which corresponds to enhanced
red signal 514 of adaptive filter 512 in FIG. 5B,t is a lag
value and n is discrete time. Both n and t are integers
representing time indices. The auto correlation sequence has
its maximum value at lag zero and integer multiples of its
fundamental period, T,. In one embodiment, the autocorre-
lation function is linearly combined with the previous auto-
correlation functions. In a preferred embodiment, the win-
dow length of the autocorrelation function is 1500 samples.
Any number of samples may be employed.
At step 704, a time domain window 705is calculated. In
this step, for each value of T in the limited range of the
period, [Tmin, Tmax], the time domain window
a,8(t-T)+a,8(t-27)+038(-37) Eq. 21
is generated where 4 is dirac delta function. a,, a, and a,
are empirically obtained as 1, 0.9, 0.8, respectively, to
enhance the accuracy of period estimator and prevent gross
errors.
At step 707, time domain window 705 is multiplied with
autocorrelation function 706 in time domain. This step
results in a modified autocorrelation function 708 for each
window,whichis zero for all values oft except T, 2T and 3T.
Different time domain windows may be used. History of
heart rate may be used in computation of the heart rate.
At step 709, a summation is computed for all modified
autocorrelations, at a set of values of T.
At step 710, the window passing maximum energy
through the autocorrelation function is determined, which
defines a fundamental period 711 T,
In one embodiment, decreasing amplitude of the time
window is considered to reduce susceptibility to period
doubling. The extracted fundamental period, T,, is used in
prediction errorfilter to find the optimum £.
Since method 700 determines the window passing maxi-
mum energy instead of searching for peaks in the autocor-
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relation function, this methodis particularly well-suited for
noisy environments of wearable sensors.
In one embodiment, the time window, «,6(t-T)+a.,6(t-
2T)+a,6(t-3T), is used that represents a train of pulses with
fundamental frequency f,, which reduces the leakage from
motion noise components. In this embodiment, the fre-
quency domain is determined by finding f,, such that maxi-
mum correlation exists between spectrum of the time win-
dow and the spectrum of PPG signal. Different window
types may be designed and optimized for the PPG signal in
the presence of motion artifact.
Referring to FIG. 8 in another embodiment, a real-time
method 800 for adaptive noise cancellation using a gener-
ated synthetic noise reference based on the fundamental
frequency is shown. A primary input signal 801, i.e. s(n)+
d(n) contains a raw PPGsignal corrupted by motion noise.
Estimator 802 uses primary input signal 801 to generate an
estimated fundamental frequency 803. In a preferred
embodiment, method 700 is used to estimate the fundamen-
tal frequency 803.
A reference noise signal 805 g(n) is generated by comb
filter 804. In a preferred embodiment, a combfilter with a
transfer function (1-z-™)/2 is applied to the primary input
signal 801 where T, is the fundamental frequency 803.
Reference noise signal 805, g(n) is highly correlated with
motion artifact.
Adaptive filter 806 generates an estimate of motion noise
807 d(n) from reference noise signal 805. The estimate of
motion noise 807 is subtracted from primary input signal
801 at 808 to reduce the noise level and generate enhanced
signal 809 and error signal 810. Adaptive process 811 adapts
adaptive filter 806 to minimize power in error signal 810
e(n) by self-adjusting coefficient 812 using a Least Mean
Squares method to minimize an error cost function, as
previously described.
Referring to FIG. 9 in another embodiment, motion-
tolerant system 900 includes signal enhancement unit 901
and cardiac gating SpO, unit 902. After conditioning the
received red and infrared signals by low pass filtering,
preprocessedred signal 903 and preprocessedinfrared signal
904 enter signal enhancement unit 901 and the quality of
preprocessedred signal 903 and preprocessedinfrared signal
904 are improved using adaptive filtering approaches to
generate enhanced red signal 905 and enhanced infrared
signal 906. Cardiac gating SpO, unit 902 calculates SpO,
907 using enhanced red signal 905 and enhanced infrared
signal 906.
Referring to FIG. 10, signal enhancementunit 901 will be
further described as signal enhancement unit 1000. Linear
phase digital filters 1003 and 1004 remove baseline changes
from red signal 1001 andinfrared signal 1002, respectively,
to generate red baseline signal 1005 and infrared baseline
signal 1006. Red and infrared LEDs may emit light with
different intensities and photodetectors may have different
sensitivity at red and infrared wavelengths. Further, the
physical condition of site of a measurement suchastissue,
bone and skin properties and the length of the measurement
site are different from patient to patient. Therefore, red
baseline signal 1005 and infrared baseline signal 1006 must
be normalized. In a preferred embodiment, each of red
baseline signal 1005 and infrared baseline signal 1006,
which shows the mean of the signal over time, is used to
normalize red baseline signal 1005 and infrared baseline
signal 1006 to generate normalized red signal 1009 and
normalized infrared signal 1010.
TheAC component ofnormalized red andinfrared signals
1009 and 1010 becomes independent of intensity of LEDs
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and photodetector nonlinear effect. Therefore, they can
effectively be compared with each other in parameter extrac-
tion units such SpO, measurement. After the baseline
removal and normalization of red and infrared signals, an
intermediate reference signal 1012 is generated by reference
signal generator 1011 by subtracting normalized red signal
1009 and normalized infrared signal 1010.
Intermediate reference signal 1010 is used by each of FIR
adaptive filter 1013 and FIR adaptivefilter 1014. Generally,
any correlation canceller can be used for FIR adaptivefilter
1013 and FIR adaptive filter 1014. In a preferred embodi-
ment, each of FIR adaptive filter 1013 and FIR adaptive
filter 1014 is adaptive noise canceller 610. The output of
each FIR adaptive filter is a filtered signal and an error
signal. FIR adaptive filter 1013 outputs filtered red signal
1015 and FIR adaptive filter 1014 outputs filtered infrared
signal 1016.
Each filtered signal has a harmonic structure, which is
used to further enhance the signal quality in the presence of
motion artifact. A harmonic enhancementprocess is used to
enhance the harmonic structure of each filtered signal in the
presence of motion. In the harmonic enhancement process,
adaptive comb filters 1017 and 1018 adapt to filtered red
signal 1015 andfiltered infrared signal 1016, respectively,
with a single parameter, fundamental period or fundamental
frequency of the respective signal. In a preferred embodi-
ment, fundamental period 1019 is generated and used to
adapt each of adaptive comb filters 1017 and 1018, as will
be described below. The output of adaptive combfilter 1017
is an enhancedred signal 1020. The output of adaptive comb
filter 1018 is an enhanced infrared signal 1021.
Another issue in ambulatory and portable applications is
reliable acquisition of the signals. Presence of the motion
leads to fluctuation on baseline and amplitude ofthe signals
and there is a need for a way of controlling the analog front
end which prevents nonlinear clipping and provides appro-
priate signal amplitude at the input of enhancement unit
1000. In order to prevent clipping and use the available
dynamic range of amplifier 1025 in the analog front end, a
digital gain and intensity controller 1022 is included.
Each of red baseline signal 1005 and infrared baseline
signal 1006 is measured over time and a moving average
filter is applied on each signal by digital gain and intensity
controller 1022. An amplitude of each signal after baseline
removal is computed. The photo-detector gain 1023 and
LEDintensity 1024 is adjusted based on the baseline andAC
value of infrared baseline signal 1006. LED intensity 1024
is converted with digital-to-analog converter 1026 for LED
drivers 1027. LED drivers 1027 drive the LEDsfor the red
and infrared light based on LED intensity 1024. The
received photo-detector signal is amplified based on the
photo-detector 1023 and converted with analog-to-digital
converter 1028.
In order to reduce the accumulated effect of motion
artifact, SpO, is preferably calculated on a sub-heart beat
time duration. As will be further described below, cardiac
gating SpO, is employed on sub-heart beat cycle time
frames and determines the best time duration in each beat
cycle based on the physiology of blood circulation.
Referring to FIG. 11A, blood circulation 1100 starts by
heart pumping blood into arteries. Blood volume 1101
changes rapidly from minimum 1102 to its maximum value
called systolic peak 1103 during systole. Peak to peak
interval 1108 is the time between systolic peaks 1103 and
1105. Pulse interval 1107is the time between minimum 1102
and minimum 1106. Sampling interval 1104 is the time
between minimum 1102 and systolic peak 1103.
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Referring to FIGS. 11A, 11B, 11C, and 11D,in biphasic
cardiac activity when the left ventricular is in systole, the
blood flow and hydrodynamic pressure 1109 and 1110 is at
a maximum, ventricular ejection time is small, and blood
flow velocity is higher. The blood pressure and volume then
decrease during diastole 1111 with a slower rate. In a
preferred embodiment, the arterial oxygen saturation is
sampled and computed during systole, i.e., sampling win-
dow 1104, where the heart pushes blood into the arteries. In
this time period, the crest time, blood is mainly controlled by
heart as a pumpforcing bloodintoarteries. The amplitude of
diastolic peak 1112 in which the heart is relaxing, changes
dramatically in the presence of motion comparedto systolic
time period. Sampling window 1104 is determined during
systole and results in a motion-free sampling of the PPG
signal during each beat cycle.
In typical methods, a continuous segment of the PPG
signal at a single heartbeat or multiple heart beats is used to
compute SpO,.In the disclosed cardiac gating SpO, method,
to improve signal quality, a motion-free short segment of
signal in each heart beat is chosen from two or more
subsequent cardiac cycles to compute SpO,. The heart rate
of the patient is an important determinant in cardiac gating.
Changesin heart rate over time result in change of location
of the motion-free sampling window and length of the
sampling window. The disclosed cardiac gating method
tracks heart rate changes and the motion-free sampling
window overtime to build two cardiac synchronized cardiac
gated red andinfrared signals from which SpO,is ultimately
calculated.
Another main contributing error in the presence ofmotion
artifact is the venous return effect of venous blood move-
ment. Venous return blood movement is governed by two
physiological processes: (i) respiratory pump and(ii) skel-
etal muscle pump. Theeffect of respiratory pump adds a low
frequency signal to the PPG signal which is in phase with
expiration and inspiration. The respiration rate is typically
between 8 to 30 breathes per minute and a respiration cycle
takes at least two heart beats. This component of the venous
return effect on the PPG signal is in low frequency region.
The limited effect of the respiratory portion ofvenous return
on the calculation of the SpO, is removed by (1) baseline
removal filters in enhancement unit 1000, as previously
described (11) computation of SpO, using the first order
derivatives of red and infrared signals (as opposedto origi-
nal red and infrared signals) and cardiac gating, as will be
further described below. Low frequency variation of the
respiratory portion of venous return changesthe baseline of
the signals and whentherespiration rate is slow, the baseline
will be removed or attenuated by baseline filters or subse-
quentfiltering in signal enhancement unit. Any remaining
respiratory related venous return effect is removed by taking
the first derivative of the red and infrared signals.
Referring to FIG. 12, graph 1200 showsan experimental
result where the user performs a deep long breathe at heart
rate of 78 beats per minute. Graph 1200 includes plots of
PPGsignal 1201, first derivative 1202 of PPG signal 1201,
and zero line 1203. Graph 1200 shows the transition
between expiration and inspiration phases which represents
baseline changes due to respiratory-related venous return.
Referring to FIG. 13, cardiac gating method 1300 for
determining a crest time duration ofa set of PPG signals will
be further described. At step 1303,a first order derivative of
enhancedred signal 1301 is taken to generatefirst derivative
red signal 1305. In this step, first derivative red signal 1305
is negated to generate negated first derivative red signal
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1319. At step 1304, a first order derivative of enhanced
infrared signal 1302 is taken to generate first derivative
infrared signal 1306.
At step 1307, a time windowis generated using a set of
conditions. The set of conditions determine time durations in
whichfirst derivative red signal 1305 is less than or equal to
zero, and first derivative infrared signal 1306 is greater than
or equal to zero. If this set of conditions exists, then the time
window valueis one.If not, then the time windowis zero.
In this step, each ofthe first order derivative infrared signal
1306 and negated first derivative red signal 1319 is multi-
plied by the time domain window to generate windowed red
signal 1309 and windowedinfrared signal 1308. The time
domain windowing step determines the desired time dura-
tion from the beginning of the systolic phase up to peak
systolic point.
Atstep 1310, heart rate 1312 is extracted using windowed
infrared signal 1308. At step 1311, windowedinfrared signal
1308 and windowed red signal 1309 are “cleaned” using
heart rate 1312 to remove the other time durations that do
not meetthe set of conditions. In order to remove unwanted
time durations on the windowed signals and clean each
signal, an autocorrelation based method derives the average
heart rate for each frameofthe data, as previously described,
to generate clean red signal 1313 and clean infrared signal
1314.
At step 1315, an optimum ratio 1316 of clean red signal
1313 to clean infrared signal 1314 is calculated in the
presence ofmotionartifact using a correlation cancellerratio
measurement, as will be further described below. At step
1317, SpO, is calculated using the optimum ratio 1316.
Referring to FIG. 14, step 1310 will be further described
as method 1400. Dueto its higher amplitude comparedto a
windowed red signal, windowed infrared signal 1401 is
segmented at step 1402. At step 1403, for each segment of
the windowed infrared signal, an autocorrelation function
(ACF) is computed in the range of time periods for human
heart rate, as previously described. At step 1404, a peak
finder finds the first dominant peak of the autocorrelation
function.
Fundamental frequency doubling is an issue in fundamen-
tal frequency (e.g heart rate) extraction techniques. In the
heart rate extraction from a motion-corrupted PPG signal,
this issue becomes more troublesomein the presence of the
motion artifact which changes the shapeofthe signal in time
domain.
Atstep 1405, a frequency checker removes any frequency
doubling. Amplitude of the signal in unwanted time dura-
tions is less than amplitude of the signal in the peak systolic
point. Therefore, a sliding window with the length of three
by average of number of samples in each heart beat moves
on the signal. Within this window, the time durations whose
peak value of the signal is less than a predetermined thresh-
old multiplied by a mean value are removed. In a preferred
embodiment, the predetermined threshold is 0.7. On the
modified signal at this point, an autocorrelation function is
computed and a peak finder finds the peak value of the
autocorrelation function. The maximum peak is chosen for
the current window to generate a fundamental frequency
1406, which is the heart rate.
Referring to FIG. 15, step 1315 will be described as
correlation canceller 1500. Correlation canceller 1500 uses
clean infrared signal 1501 as a reference signal (y,,) in a
correlation canceller loop. The ratio vector 1503 R,, of length
N is available at time n. At step 1504, an estimated infrared
signal 1505 x,, is computed by linear combination of R
samples of clean infrared signal 1501 y,,. At step 1506, an
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error estimation signal 1507 is calculated by e(n)=x(n)-x,,
using clean red signal 1502 x(n) and estimated infrared
signal 1505 x,,. At step 1508, next ratio vector 1509 R,,, , is
calculated by minimizing mean square error of error esti-
mation signal 1507 e(n) with respectto ratio vector R,,. Steps
1504, 1506, and 1508 are repeated for next sample, n+1.
After computing the next ratio vector 1509 of length N,
the mean value of ratio vector 1509 is computed and
multiplied by the length of the ratio vector N at step 1510 to
build a current optimum ratio 1511 of red to infrared light
intensities. As seen in FIG. 15, the adaptiveiterative solution
is a gradient-decent method which results in the calculation
of the final ratio value from which SpO,is derived.
Test 1
Referring to FIG. 16, experimental sensor platform setup
1600 includes a finger probe 1601 with red LED andinfrared
LED, respectively, connected to analog and sampling unit
1602, which is connected to computer 1603. Analog and
sampling unit 1602 includes an analog conditioning circuit
which limits the bandwidth of the PPG signal to 70 Hz. The
PPG signal is acquired with sampling rate of 250 Hz using
a battery powered module with an analog front end circuit
and with an onboard processor. A hamming window and a
low-pass filter, with cutoff frequency at 8 Hz, are imple-
mented on the evaluation module in order to attenuate any
unwanted signals. Other sensors on various locations of the
body and reflection or transmission mode sensors may be
employed.
For the performance evaluation, each participant wore a
commercially available wireless ECG sensor 1603 and SpO,
sensor 1604, each of which is connected to computer 1603
via Bluetooth. The experiment was performed on a treadmill
to maintain control over speed and durations. To test and
validate the disclosed methods, the PPG signal is collected
from different subjects performing various motions. Three
experiments are designedto observe effect ofmotion artifact
and quantify signal enhancement using objective and sub-
jective tests.
The motion types in this test are standing still, up-down
“vertical” hand movement, andleft-right hand motions of
the hand with different speed and acceleration, bending of
the finger, walking and running at different speeds. Six
subjects between ages of 19-50 participated in the experi-
mentation. For the objective test, an experiment was
designed to validate the performance of the disclosed
method during normal physical activities (standing, walking
and running) Oneparticipant, male 28 years old, performed
a 30 minute exercise test. This exercise test consisted of 5
minutes walking at 1 mph, 5 min walking at 2 mph, 5
minutes walking in 3 mph, 5 minutes running at 4 mph, 5
minutes running in 5 mph and then a 5 minutes cool down.
The cool down included 1 minute running at 4 mph, 1
minute walking at 3 mph, 1 minute walking at 2 mph, 1
minute standing at rest. Six participants completed con-
trolled subjective experiment by walking on the treadmill for
1.5 minutes at 2 mph, then running at the speed of 3.5 mph
for another 1.5 minutes andfinally running for 2 minutes at
5 mph.
Referring to FIG. 17A, graph 1700 shows noisy PPG
signal 1701 collected to observe effect of motion artifact
through various motions at different time periods. At seg-
ment 1702 the user is standing in place. At segment 1703,
the user is moving his hand up and down. At segment 1704,
the user is moving his handleft to right. At segment 1705,
the user is bending the finger to which the PPG sensoris
attached. At segment 1706, the user is walking and running.
Referring to FIG. 17B, graph 1707 showsplots 1708 and
1709 of the time domain of the original signal and the
enhanced signal, respectively. As can be seen, motion arti-
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fact has changed the shape and periodicity of plot 1708 of
the original signal. Motion artifact is removed in plot 1709
of the enhanced signal.
Retelling to FIG. 17C, graph 1707 showsplots 1711 and
1712 of the autocorrelation function of the original signal
and the enhanced signal, respectively. Improvement of the
autocorrelation function is observed from plot 1711 of the
original signal to plot 1712 of the enhanced signal, which
enables a reliable heart rate computation.
Referring to FIG. 17D, graph 1713 showsplots 1714 and
1715 of the frequency content of the original signal and the
enhancedsignal, respectively.
After reducing the effect of motion, heart rate and SpO,
are computed every 6 sec (e.g. 1500 samples) with no
overlap between frames of data for noisy PPG signal 1701.
Referring to FIG. 17E, graph 1716 showsplots 1717 and
1718 of the extracted heart rate from the original signal and
the enhanced signal e.g. after removal of tissue effect,
respectively. The fundamental period, extracted using
method 1400, is used for computation of the heart rate for
the enhanced signal 1718. As seen, after enhancing the
signal, a robust heart rate computation is provided.
Referring to FIG. 17F, graph 1719 shows plots 1720 and
1721 ofthe SpO,calculation from the original signal and the
enhanced signal, respectively. SpO, computation is very
sensitive to motion. The SpO, values extracted from the
original signal in plot 1720 is unreliable while the enhanced
signal e.g. after removal of tissue and venouseffect in plot
1721 provides robust computation of the SpO,.
Referring to FIGS. 18A and 18B, spectrogram 1801 ofthe
original signal and spectrogram 1802 of the enhancedsignal
are respectively shown. Spectrograms 1801 and 1802 show
the effect of motion on the PPG signal. Each spectrogram is
computed using Short-Time Fourier Transform (“STFT’)
with window size of 2048, overlap size of 1024 and 4096
point Fast Fourier Transform (“FFT”). High power noise
component which leads to inaccurate and unreliable com-
putation of the heart rate and SpO, is seen in spectrogram
1801. The removal of high power noise components in
spectrogram 1802 leads to restoration of the true power of
the signal. Harmonic enhancement is observed in spectro-
gram 1802 which results in enhancementof the autocorre-
lation function and reliable heart rate computation.
Referring to FIGS. 19A and 19B, graphs 1900 and 1902
show ECGsignal curve 1901 and PPGsignal curve 1903,
respectively, collected using the ECG sensorandthe finger
clip PPG sensor, respectively, during the experiment. As
shown by ECGsignal curve 1901 and PPG signal curve
1903, there is a corresponding peak value for every QRS
complex of ECG waveform.
Referring to FIG. 19C, graph 1904 depicts reference heart
rate 1905, original heart rate 1907, and enhancedheart rate
1906.
Referring to FIGS. 19D and 19EF, graph 1908 plots
original heart rate 1909 and graph 1919 plots enhanced heart
rate 1911. Graphs 1908 and 1910 show the difference
between heart rate computed using original and enhanced
signals, respectively.
Referring to FIG. 19F, graph 1912 includes the computed
SpO, for reference stationary signal 1913, original signal
1915, and enhanced signal 1915. As can be seen, before
applying the disclosed embodiments, in many casesthe ratio
of ratios fails to compute the SpO,.
Bland-Altman difference plots were used to analyze the
agreement between results from the disclosed embodiments
and reference measurements. Limit ofAgreement (LOA) in
this analysis is defined as average difference +1.96 standard
deviation ofthe difference ([u-1.960, U+1.96 o]). 95% ofall
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differences lies inside the LOA.Heart rate and SpO, values
are extracted every 6 second. 300 pairs of heart rate mea-
surement are obtained.
Referring to FIGS. 19G and 19H,graphs 1916 and 1918
include the Bland-Altman plot for SpO, computed using
original signal 1917 and enhancedsignal 1919, respectively.
Acorrelation coefficient is defined as the covariance ofthe
variables divided by their standard deviations. Correlation
and agreement analyses are compared in Table 1 below.
Muchhigher correlation and agreement are achieved after
enhancing the original signal with the disclosed embodi-
ments for SpO, and heart rate. The correlation coefficient of
SpO, measurement after applying the disclosed embodi-
ments was 0.71 with p-value, i.e., the probability of obtain-
ing a correlation as large as the one obtained randomly, less
than 0.00001. There is no correlation between SpO, com-
puted from the original signal due to high power noise
componentin the original signal. For the purpose of com-
parison, the DST method is also implemented using an
adaptive filter of order 32 . Reference signals are generated
by sweeping SpO, with step size of 0.01 from 0% to 100%.
SpO, is computed by finding the rightmost peak of the
powerplot and results are summarized in Table 1 below.
There is a low correlation between the DST method and the
reference SpO, measurements. The disclosed embodiments
enhancethe original signal to provide a morereliable SpO,
reading with higher correlation.
TABLE1
 
COMPARISON OF HEART RATE AND
SpO, ACHIEVED BEFORE AND AFTER ALGORITHM
Mean Mean Abs.
Parameters Corr. Bias Bias LOA
Heart Rate (Orig.) 0.91 -2.3 8.7 [-23.5, 19.0]
Heart Rate (Enh.) 0.99 0.36 2.1 [-5.3, 6.0]
SpO, (Orig./Eqn. (19)) 0 -1.8 6.9 [-26.5, 23.0]
SpO, (Orig./DST) 0.1 -5.3 25.6 [-54.3, 43.9]
SpO, (Enh.) 0.73 0.15 0.6 [-1.3, 1.6]
 
Referring to FIG. 20, graph 2000 shows commonerrors
where the DST methodreports a false reading due to motion
artifact. To observe the behavior of the output powerplot,
SpO, is intentionally swept in a larger range. The DST
method expects multiple peaks in the range of 0% to 100%
where the assumption is that the right-most peak corre-
sponds to arterial oxygen saturation. The amplitude of the
peak associated with arterial oxygen saturation is typically
very small as shownin curve 2002. These peaks can easily
be affected and concealed by motion artifact as shown in
curves 2001 and 2002 where there is no peak related to
arterial oxygen saturation on curve 2001. In curves 2003 and
2004, not only the peaks are affected by motion artifact but
also curves 2003 and 2004 are increasing functions of SpO,
in the range 0% to 100%. To compare the disclosed embodi-
ment versus the DST method more specifically, we com-
puted the correlation coefficient for various levels of
motions, i.e. 1 mph, 3 mph, 5 mph. The correlation coeffi-
cient for the disclosed embodiments were 0.85, 0.78, 0.64
and 0.52, 0.09, 0.03, for the DST method.
Referring to FIGS. 21A and 21B, graphs 2101 and 2102
show the Bland-Altmanplot show results for heart rate 2103
and SpO, 2104, respectively. A total of 300 heart rate
measurementpairs and 295 valid SpO, readings were com-
puted after enhancement of the red and infrared signals.
Results of this experimentation are summarized in Table 2,
below. These results for multi-subject experiment overall
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show a high level of agreement and correlation between
reference measurements and the disclosed method.
TABLE 2
 
EVALUATION ON MULTI-SUBJECT EXPERIMENT
Mean Mean Abs.
Parameters Corr. Bias Bias LOA
10 Heart Rate 0.98 -0.57 2.7 [-7.0, 5.9]
SpO, 0.7 -0.35 0.71 [-1.9, 1.2]
In order to observe sensitivity offiltering to rapid changes
of heart rate, the beat-to-beat heart rate was extracted after
enhancing the noisy signal with the second stage of the
disclosed method while using autocorrelation-based funda-
mental period extractor and update rule for B,,,,
Dueto high similarity of Blood Pressure (BP) signal with
the PPG signal, a BP signal from the MIT-BIH polysomno-
graphic database, dataset “slp01a” was used to evaluate the
beat-to-beat heart rate. This database includes BP and ECG
signals. For evaluation purposes, a reference heart rate is
derived from the annotated ECGsignal in the database. The
BP signal is standardized to have zero mean and unity
variance. Noise is artificially added to 1 hour of clean BP
signal and signals x, and x, are generated according to Eq.
8 with r,=0.9 and r,=0.6, which are typical optical density
ratios in artery and vein, also in Eq. 7. The noise .W (0,1)
is filtered with a FIR low passfilter with a cutoff frequency
of 8 Hz and multiplied by a gain factor to have unity
variance in x,
To extract the beat-to-beat heart rate from the BP signal,
a threshold-based method is used which finds the maximum
point on the signal in each cycle. The BP signal is converted
to frames of size 700 samples. For each new frame, the mean
value is subtracted from the signal and a clipping level is
extracted by computing a fixed percentage of the maximum
amplitude of the signal in that frame. The center clipped
signal, i.e., the original signal minus the clipping level, is
extracted and a peak finder finds the location of the peak
value on the center clipped waveform. The results are
summarized in Table 3 below. Therelative error in Table 3
is used for quantifying beat-to-beat HR and defined as:
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Eq. 22N
Error= 1 atror= |— e> Ref
where N is the total number of beats, HR is the measured
heart rate, and Ref is the reference heart rate obtained from
the annotated ECG signal in the database.
50
 
55 TABLE3
BEAT-TO-BEAT HR
Mean Mean Abs.
60 Parameters Error Corr. Bias Bias LOA
Orig. Clean BP 0.021 0.99 0 1.12 [-4.28, 4.28]
Noisy BP Signal 0.49 0.78 0.10 8.22 [-21.12, 21.24]
Enh. BP Signal 0.024 0.98 0 1.32 [-4.59, 4.59]
65 The simulation using MIT-BIH database showsthat beat-
to-beat heart rate is reliably extracted using the disclosed
method even though there is an estimation error in the
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fundamental period due to rapid changes of the heart rate.
Dueto rapid changesin heart rate and high power of added
noise, a threshold-based method has poor performance in
extracting the heart rate from a noisy BP signal even though
threshold is adaptively adjusted to have thebest result. There
is a high correlation between beat-to-beat heart rate from the
enhancedsignal and the reference beat-to-beat heart rate. To
further reduce the effect ofrhythm irregularities on reference
noise in special applications, the disclosed method can be
tuned appropriately based on features that are supposed to be
extracted from the enhanced output signals for that particu-
lar application. For example, the size of autocorrelation
window can be tuned based on the rate of changes of heart
beat or it can be replaced with an available reliable beat-to-
beat heart rate extractor.
Test 2
To evaluate the disclosed real-time fundamental estima-
tion method of FIG. 7, corrupted and noisy PPG signal
named a44091c dataset from MIT MIMIC II waveform
database is used. The sampling frequency ofthis database is
125 Hz andtotal numberofsimulated samples is 360000, 48
minutes of data gathered from an Intensive Care Unit (ICU)
monitor.
Referring to FIG. 22, plot 2201 of graph 2200 shows a
small portion (72 sec) of noisy signal of this dataset. This
sample of data includes a noise-free segment from approxi-
mately t=18 to approximately t=30 and a noisy segment
from approximately t=50 to approximately t=72.
Referring to FIGS. 23A, 23B, 23C, and 23D, graph 2301
includes plot 2302 of raw PPG signal. Graph 2303 includes
plot 2304 of the extracted fundamental frequency using the
disclosed real-time fundamental frequency estimation
method. Graphs 2305 and 2307 include plots 2306 and 2308
of the disclosed autocorrelation method. The heart rate is
almost stable and the fundamental frequency is about 1 Hz
as it can be visually confirmedby plot 2304. The result ofthe
disclosed fundamental frequency estimation method is
shownin plot 2304. As can be seen, the frequency estimation
method has no error providing a robust estimation of the
fundamental frequency.
In the autocorrelation method, the corresponding autocor-
relation function is computed and a peak searching is used
to find the fundamental frequency between 0.6 Hz and 3.3
Hz. In this experiment, 2000 data samples are used for
computation of autocorrelation. As previously discussed, the
autocorrelation function does not provide a robust estima-
tion of fundamental frequency. Several of erroneous outputs
are marked by “*” on plots 2306 and 2308.
A data collection platform is developed using a finger
probe with a red LED and an infrared LED working on 660
nm and 895 nm,respectively. An analog conditioning circuit
limits bandwidth of the PPG signal to 70 Hz and the PPG
signal is acquired with sampling rate of 250 Hz using a
module with an analog front end circuit and with an onboard
processor. An FIR hamming window and a low-passfilter
with a cutoff frequency at 10 Hz attenuates the unwanted
signals.
To validate the embodiments using synthetic noise gen-
eration on real data, the PPG signal from a user performing
different motions is collected for 12 minutes. Referring to
FIG. 24A, graph 2401 includes plot 2402 of the PPG signal.
Plot 2402 includes segment 2403 of clean data without
motion (“No Motion”), segment 2404 of vertical movement
of the hand (““UP-Down Motion”), segment 2405 of hori-
zontal movement of the hand (“Left-Right Motion”), seg-
ment 2406 bending of the finger (“Bending”), and segment
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2407 of walking. Movements have different accelerations
and variations within each segment.
Referring to FIGS. 24B and 24C, graph 2409 includes
plot 2410 of the fundamental frequency calculated by the
disclosed fundamental frequency estimation method. Graph
2411 includes plot 2412 of the autocorrelation function.
2500 samples of data are used for computation of the
autocorrelation function in both autocorrelation and the
fundamental frequency estimation method andresults are
shown. The disclosed method shows superior and robust
performance compared to autocorrelation function in which
many errors have occurred during bending of the finger and
walking from approximately 6 minutes to approximately 12
minutes.
Referring to FIGS. 25A, 25B, and 25C, graph 2501
includesplot 2502 of a motion corrupted PPG signal during
left-right movementof the hand. Graph 2503 includes plot
2504 of an improved PPG signal, s(n), at the output of
adaptive filter during left-right movement of the hand.
Graph 2505 includes plot 2506 of a synthetic noise reference
in time domain during left-right movement of the hand.
Referring to FIGS. 26A, 26B, and 26C, spectrogram 2601
includes spectrum 2602 of a motion corrupted PPG signal.
Spectrogram 2603 includes spectrum 2604 of an improved
PPG signal. Spectrogram 2605 includes spectrum 2606 of a
synthetic noise reference. As shown, motion artifact com-
ponents are picked up by the combfilter and the adaptive
LMSfilter significantly improves the signal spectrogram by
reducing noise components of the spectrogram. A normal-
ized LMSadaptive filter of order 20 is used in this experi-
ment.
It will be appreciated by those skilled in the art that the
described embodiments disclose significantly more than an
abstract idea including technical advancements in the field
of data processing and a transformation of data which is
directly related to real world objects andsituations in that the
disclosed embodiments enable a computer to operate more
efficiently and improve medical diagnoses and treatments.
Specifically, the disclosed embodiments enhance and clean
PPG signals by removing signal noise due to motion and
venous blood. The clean PPG signals allow for a faster and
more accurate calculation of SpO, and heart rate. The faster
and more accurate calculation of SpO, and heart rate enables
more accurate and faster diagnoses and treatment ofmedical
ailments.
It will be appreciated by those skilled in the art that
modifications can be made to the embodiments disclosed
and remain within the inventive concept. Therefore, this
invention is not limited to the specific embodiments dis-
closed, but is intended to cover changes within the scope and
spirit of the claims.
The invention claimedis:
1. A method for enhancing a set of photoplethysmo-
graphic signals to calculate a blood oxygen level and a heart
rate comprising the steps of:
removing motion noise from the set of photoplethysmo-
graphic signals to generate a set of enhancedsignals;
extracting a fundamental period from the set of enhanced
signals;
determining a venous noise reference from the set of
enhanced signals and the fundamental period;
generating a set of clean signals from the set of enhanced
signals and the venous noise reference; and,
calculating the heart rate and the blood oxygenlevel from
the set of clean signals.
2. The method of claim 1, wherein the step of removing
further comprises the steps of:
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generating a reference signal from the set ofphotoplethys-
mographic signals; and,
filtering motion noise from the set of photoplethysmo-
graphic signals using the reference signal.
3. The method of claim 2, wherein the step of filtering
further comprises the steps of:
determining afirst set of filter criteria;
generating firstfilter coefficient from the first set offilter
criteria;
applyingthefirst filter coefficient to the reference signal
to generate the set of enhanced signals;
generating a first error estimation from the set of
enhancedsignals and the set of photoplethysmographic
signals; and,
updating the first filter coefficient based on the first error
estimation.
4. The method of claim 2, wherein the step of extracting
a fundamental period further comprises the steps of:
calculating an autocorrelation function of the set of
enhancedsignals;
calculating a set of time domain windows;
generating a modified autocorrelation function for each of
the set of time domain windows;
combining each modified autocorrelation function at a
subset of the set of time domain windows;
determining a maximum energy level from the subset of
the set of time domain windows; and,
determining the fundamental period from the maximum
energy level.
5. The method of claim 1, wherein the set of enhanced
signals further comprises an enhanced red signal and an
enhancedinfrared signal, wherein the step of determining a
venous noise reference further comprises the steps of:
extracting an arterial scaled estimate from the set of
enhancedsignals;
generating a weight based on thearterial scaled estimate;
generating a first error signal from the weight and the
arterial scaled estimate;
generating an optimized weight from the weight by mini-
mizing a variance of the first error signal using the
fundamental period; and,
generating the venous noise reference from the enhanced
red signal, the enhanced infrared signal, and the opti-
mized weight.
6. The method of claim 1, wherein the step of generating
a set of clean signals further comprises the steps of:
determining a secondset offilter criteria;
generating a secondfilter coefficient from the second set
offilter criteria;
applying the secondfilter coefficient to the venous noise
reference to generate an output;
generating a seconderror estimation and the set of clean
signals from the output andthe set of enhancedsignals;
and,
updating the secondfilter coefficient based on the second
error estimation.
7. The method of claim 1, wherein the step of removing
further comprises the steps of:
generating an estimated fundamental frequency from the
set of photoplethysmographic signals;
generating a reference noise signal from the estimated
fundamental frequency and the set of photoplethysmo-
graphic signals;
generating an estimated motion noise from the reference
noise signal; and,
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generating a seconderror signal and the set of enhanced
signals from the set of photoplethysmographic signals
and the estimated motion noise.
8. The method of claim 7, further comprising the step of
adjusting a filter coefficient to minimize the second error
signal.
9. A method for motion-tolerant processing of a set of
photoplethysmographic signals to calculate a blood oxygen
level comprising the steps of:
generating a set of processed signals from the set of
photoplethysmographic signals;
generating a set of enhanced signals from the set of
processed signals;
calculating the blood oxygen level from the set of
enhancedsignals;
wherein the step of generating a set of enhanced signals
from the set of processed signals further comprises the
steps of:
removing a set of baseline changes from the set of
processed signals to generate a set of baseline sig-
nals;
normalizing the set of baseline signals to generate a set
of normalized signals;
generating an intermediate reference signal from the set
of normalized signals;
filtering the set of normalized signals with the inter-
mediate reference signal to generate a setof filtered
signals;
receiving a fundamental period; and,
generating the set of enhanced signals from the set of
filtered signals and the fundamental period.
10. The method of claim 9, further comprising the steps
of:
generating a photodetector gain and an LED intensity
from the set of baseline signals;
driving a set of LEDs with the LED intensity; and,
amplifying a photodetector signal with the photodetector
gain.
11. The method of claim 9, wherein the set of enhanced
signals further comprise an enhanced red signal and an
enhancedinfrared signal, and wherein the step of calculating
the blood oxygen level from the set of enhanced signals
further comprises the steps of:
generating a time window from the enhancedred signal
and the enhanced infrared signal based on a set of
conditions;
generating a windowedred signal from the time window
and the enhanced red signal;
generating a windowed infrared signal from the time
window and the enhancedinfrared signal;
extracting the fundamental period from the windowed
infrared signal;
generating a clean infrared signal from the windowed
infrared signal and the fundamental period;
generating a clean red signal from the windowed red
signal and the fundamental period;
calculating an optimum ratio from the clean infrared
signal and the clean red signal; and,
calculating the blood oxygen level from the optimum
ratio.
12. The method ofclaim 11, wherein the step of extracting
the fundamental period from the windowedinfrared signal
further comprises the steps of:
segmenting the windowed infrared signal into a set of
segmented windowed infrared signals;
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calculating an autocorrelation function for each ofthe set
of segmented windowedinfrared signals to generate a
set of autocorrelation functions;
determining a peak for each of the set of autocorrelation
functions;
removing a doubled frequency from the set of segmented
windowedinfrared signals using the peak to generate a
modified signal; and,
determining a maximum peak from the modified signal to
generate the fundamental frequency.
13. The method of claim 11, wherein the step of calcu-
lating an optimum ratio further comprises the steps of:
calculating an estimated infrared signal from the clean
infrared signal;
calculating an error estimation signal from the clean red
signal;
calculating a ratio vector from theerror estimation signal;
calculating a mean from the ratio vector; and,
calculating the optimum ratio from the mean.
14. A system for enhancing a set of photoplethysmo-
graphic signals to calculate a blood oxygen level and a heart
rate comprising:
a evaluation module;
a set of photoplethysmographic sensors, each photopl-
ethysmographic sensor connected to the module;
a computing device connected to the module and pro-
grammedto carry out the steps of:
removing motion noise from the set of photoplethys-
mographic signals to generate a set of enhanced
signals;
extracting a fundamental period from the set of
enhancedsignals;
determining a venous noise reference from the set of
enhanced signals and the fundamental period;
generating a set of clean signals from the set of
enhanced signals and the venous noise reference;
and,
calculating the heart rate and the blood oxygen level
from the set of clean signals.
15. The system ofclaim 14, wherein the computing device
is further programmedto carry out the stepsof:
generating a reference signal from the set ofphotoplethys-
mographic signals; and,
filtering motion noise from the set of photoplethysmo-
graphic signals using the reference signal.
16. The system ofclaim 15, wherein the computing device
is further programmedto carry out the stepsof:
determining afirst set of filter criteria;
generating firstfilter coefficient from the first set offilter
criteria;
applyingthefirst filter coefficient to the reference signal
to generate the set of enhanced signals;
generating a first error estimation from the set of
enhancedsignals and the set of photoplethysmographic
signals; and,
updating the first filter coefficient based on the first error
estimation.
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17. The system ofclaim 15, wherein the computing device
is further programmedto carry out the stepsof:
calculating an autocorrelation function of the set of
enhancedsignals;
calculating a set of time domain windows;
generating a modified autocorrelation function for each of
the set of time domain windows;
combining each modified autocorrelation function at a
subset of the set of time domain windows;
determining a maximum energy level from the subset of
the set of time domain windows; and,
determining the fundamental period from the maximum
energy level.
18. The system of claim 14, wherein the set of enhanced
signals further comprises an enhanced red signal and an
enhancedinfrared signal, and wherein the computing device
is further programmedto carry out the stepsof:
extracting an arterial scaled estimate from the set of
enhancedsignals;
generating a weight based on thearterial scaled estimate;
generating a first error signal from the weight and the
arterial scaled estimate;
generating an optimized weight from the weight by mini-
mizing a variance of the first error signal using the
fundamental period; and,
generating the venous noise reference from the enhanced
red signal, the enhanced infrared signal, and the opti-
mized weight.
19. The system ofclaim 14, wherein the computing device
further programmed to carry out the steps of:
determining a secondsetoffilter criteria;
generating a secondfilter coefficient from the second set
of filter criteria;
applying the secondfilter coefficient to the venous noise
reference to generate an output;
generating a seconderror estimation and the set of clean
signals from the output andthe set of enhancedsignals;
and,
updating the secondfilter coefficient based on the second
error estimation.
20. The system ofclaim 14, wherein the computing device
further programmed to carry out the steps of:
generating an estimated fundamental frequency from the
set of photoplethysmographic signals;
generating a reference noise signal from the estimated
fundamental frequency and the set of photoplethysmo-
graphic signals;
generating an estimated motion noise from the reference
noise signal; and,
generating a seconderror signal and the set of enhanced
signals from the set of photoplethysmographic signals
and the estimated motion noise.
21. The system ofclaim 20, wherein the computing device
is further programmed to carry out the step of adjusting a
filter coefficient to minimize the seconderror signal.
* * * * *
